Ignite Creation Date:
2025-12-25 @ 1:32 AM
Ignite Modification Date:
2026-02-02 @ 9:07 PM
Study NCT ID:
NCT06930794
Status:
RECRUITING
Last Update Posted:
2025-12-05
First Post:
2025-02-27
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Study of Vebreltinib and Platinum-Containing Double Agents in Subjects With MET Amplification.
Sponsor:
Beijing Pearl Biotechnology Limited Liability Company
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
PLB1001-IIIb-NSCLC-02
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None